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Introduction
The goal of this study was to identify genetic determi-
nants of plasma N-terminal proatrial natriuretic peptide
(NT-proANP) in the general community by performing
a large-scale genetic association study and to assess its
functional significance in in vitro cell studies and on dis-
ease susceptibility.
Methods and results
Genotyping was performed across 16,000 genes in 893
randomly selected individuals, with replication in 891
subjects from the community. Plasma NT-proANP1–98
concentrations were determined using a radioimmu-
noassay. Thirty-three genome-wide significant single-
nucleotide polymorphisms were identified in the
MTHFR-CLCN6-NPPANPPB locus and were all repli-
cated. To assess the significance, in vitro functional
genomic studies and clinical outcomes for carriers of a
single-nucleotide polymorphism rs5063 (V32M) located
in NPPA that represented the most significant variation
in this genetic locus were assessed. The rs5063 variant
allozyme in transfected HEK293 cells was decreased to
55±8% of wild-type protein (p=0.01) as assessed by
quantitative western blots. Carriers of rs5063 had lower
NT-proANP levels (1427 versus 2291 pmol/L; P<0.001)
and higher diastolic blood pressures (75 versus 73 mm
Hg; p=0.009) and were at an increased risk of stroke
when compared with wild-type subjects independent of
age, sex, diabetes mellitus, hypertension, atrial fibrilla-
tion, and cholesterol levels (hazard ratio, 1.6; p=0.004).
Conclusion
This is the first large-scale genetic association study of
circulating NT-proANP levels performed with replica-
tion and functional assessment that identified genetic
variants in the MTHFR-CLCN6-NPPA-NPPB cluster to
be significantly associated with NT-proANP levels. The
clinical significance of this variation is related to lower
NT-proANP levels, higher blood pressures, and an
increased risk of stroke in the general community.
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